Healthcare hedge fund Rhenman eyes further gains after second double-digit return

Healthcare data

Rhenman & Partners Asset Management, a Stockholm-based sector-specialist hedge fund firm, says 2020 is poised to be “a good year” for its flagship healthcare strategy, after it posted a double-digit return for the second month in a row.

The Rhenman Healthcare Equity Long/Short Fund – which trades small, medium and large pharmaceuticals, biotechnology, medical technology and service company stocks – gained 10.9 per cent last month in its main euro-denominated share class.

Premium Content

To continue reading this content, please subscribe for free.